GPI is continuing to support innovation for the pharmaceutical and biotechnology industry
(PRWEB UK) 7 September 2017
Mikhael joins GPI from Accenture as Head of Technology and Development to continue GPI’s success providing powerful pharma pricing intelligence based business services to valued clients across Europe and the US. He will be based at the firm’s Global Headquarters in central London.
Preeti Patel, CEO said, “I am delighted that Mikhael is joining our team. We view his appointment as a sign of our commitment to continual improvement as the leading price and access intelligence provider in the industry.” Mikhael has an extremely strong background in the development and optimization of large-scale database and business intelligence systems. Mikhael shares our values, focus on innovation, and places the same strong emphasis on the customer experience as we do, his impeccable reputation for providing high quality service applications and solutions makes him the perfect addition for the company.” Preeti also added “GPI is continuing to support innovation for the pharmaceutical and biotechnology industry, and with Mikhael on board, the vision and forward direction of the company is further strengthened. This will allow GPI to not only remain ahead of the competition in the pharma pricing market, but to continue to increase our lead out in front, with newer, even greater innovations based upon client needs.”
Mikhael will join GPI from Accenture, where he served as a leading developer and manager of analytics & technology services. Mikhael adds, “I look forward to joining such an exciting company that is confidently setting the standard for speed, quality and ease of use of its technological solutions within the areas of pharmaceutical pricing and market access. I am excited about helping clients achieve better results via access to the latest insights, intelligence and application of modern analytics.”
GPI is an innovative market leader in business transformation consulting and technological tools for pharmaceutical pricing and access.
GPI supports price decision-making through a combination of robust data-driven insights and bespoke analytical solutions, helping the life sciences industry achieve day-to-day operational improvement and market access excellence. GPI has an expanding global presence along with innovative new tools and services developed to maximize clients’ price and value understanding enabling optimized pre-launch and post-launch decision making.
As a global company, GPI has operating units and service partners throughout the world. GPI is a privately held company headquartered in London, UK. For more information contact GPI at press(at)globalpricing.com or visit http://www.globalpricing.com or call: +44 (0) 203 874 3050